Latest news

| Wednesday, August 15th 2018

Patient information seminars in Stockholm (11.9.2018) and in Helsinki (4.10.2018)

| Wednesday, April 18th 2018

The Chemical Industry Federation of Finland’s Innovation Award to the Team of the Institute of Biotechnology and Herantis Pharma

Read More
| Wednesday, February 14th 2018

Herantis Pharma opening recruitment in Parkinson’s disease study in Helsinki and Lund based on favorable first CDNF safety assessment

Read More
| Thursday, January 18th 2018

Parkinson’s prevalence expected to increase by 18% by 2025

Read More